Petersen study of cardiometabolic health in obesity published in Cell Metabolism (Links to an external site)
Tag: max petersen
2023 Diabetes Day Symposium Recap
On November 9, in honor of World Diabetes Day, the Diabetes Research Center of the Division of Endocrinology, Metabolism and Lipid Research sponsored the 2023 Diabetes Day Symposium. The day long annual programming aims to bring scientists and trainees together to showcase their work, to foster collaboration, and to increase collective knowledge of diabetes research. […]
Department of Medicine Physicians Receive Knowlton Incentive for Excellence Award (Links to an external site)
Malik and Petersen publish study on new obesity pharmacotherapies
On July 24, Is-haq Malik, MD and Max Petersen, MD, PhD had their research titled “Glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, and glucagon receptor poly-agonists: a new era in obesity pharmacotherapy,” published in “Obesity Society.” The purpose of the study was to assess newly approved medications for treating obesity. “Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, […]
Petersen publishes review on the implications of time-restricted eating
On August 25, Max C. Petersen, MD and collaborators has their review titled “Complex physiology and clinical implications of time-restricted eating,” published in “Physiological Reviews.” Time-restricted eating (TRE) limits food consumption to certain windows of time throughout the day. Rodent models have been used to extensively study the effects of TRE on body weight and physiological […]